Cargando…

Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate

Our previous investigation of the nucleolar localisation sequence (NoLS) of chikungunya virus (CHIKV) capsid protein demonstrated the role of capsid in CHIKV virulence. Mutating the NoLS of capsid in CHIKV led to the development of a unique live-attenuated CHIKV vaccine candidate, termed CHIKV-NoLS....

Descripción completa

Detalles Bibliográficos
Autores principales:	Abeyratne, Eranga, Freitas, Joseph R., Zaid, Ali, Mahalingam, Suresh, Taylor, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465992/ https://www.ncbi.nlm.nih.gov/pubmed/30583514 http://dx.doi.org/10.3390/vaccines7010002

Ejemplares similares

Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose
por: Abeyratne, Eranga, et al.
Publicado: (2020)

Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection
por: Lucero-Obusan, Cynthia A., et al.
Publicado: (2015)

Altered Spatial and Temporal Gait Parameters in Mice Infected with Ross River Virus
por: Abeyratne, Eranga, et al.
Publicado: (2021)

Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate
por: Plante, Kenneth S, et al.
Publicado: (2015)

Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)
por: Broeckel, Rebecca, et al.
Publicado: (2015)

Chikungunya: vaccines and therapeutics
por: Tharmarajah, Kothila, et al.
Publicado: (2017)

Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective
por: Bhakat, Soumendranath, et al.
Publicado: (2015)

Genomic surveillance of the Chikungunya Virus (CHIKV) in Northeast Brazil after the first outbreak in 2014
por: Rodrigues, Ayslany Melo, et al.
Publicado: (2020)

Identification and Functional Characterization of Three NoLS (Nucleolar Localisation Signals) Mutations of the CDC73 Gene
por: Pazienza, Valerio, et al.
Publicado: (2013)

Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease
por: Mostafavi, Helen, et al.
Publicado: (2019)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
por: Chan, Yi‐Hao, et al.
Publicado: (2019)

Evaluation of the Antiviral Potential of Halogenated Dihydrorugosaflavonoids and Molecular Modeling with nsP3 Protein of Chikungunya Virus (CHIKV)
por: Puranik, Ninad V., et al.
Publicado: (2019)

Chikungunya virus (CHIKV) seroprevalence in the South Pacific populations of the Cook Islands and Vanuatu with associated environmental and social factors
por: Saretzki, Charlotte E. B., et al.
Publicado: (2022)

Approaches to the treatment of disease induced by chikungunya virus
por: Bettadapura, Jayaram, et al.
Publicado: (2013)

Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus
por: Weiss, Christopher M., et al.
Publicado: (2020)

Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism
por: Plante, Kenneth, et al.
Publicado: (2011)

Chikungunya antibodies detected in non-human primates and rats in three Indian Ocean islands after the 2006 ChikV outbreak
por: Vourc’h, Gwenaël, et al.
Publicado: (2014)

Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated In Vivo and Have Compromised Transmissibility
por: Carrau, Lucía, et al.
Publicado: (2019)

Fighting back against chikungunya
por: Rudd, Penny A, et al.
Publicado: (2015)

A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
por: Adam, Awadalkareem, et al.
Publicado: (2023)

Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design
por: Taylor, Adam, et al.
Publicado: (2017)

NiTiNol Hernia Device Stability in Inguinal Hernioplasty Without Fixation
por: Brown, Roderick B.
Publicado: (2011)

Interleukin-17 Contributes to Chikungunya Virus-Induced Disease
por: Liu, Xiang, et al.
Publicado: (2022)

Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylation
por: Rathore, Abhay P S, et al.
Publicado: (2013)

Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009–2015: Implications for its prevention and control
por: Antonio, Virgilio Santo, et al.
Publicado: (2019)

Co-Circulation of Two Independent Clades and Persistence of CHIKV-ECSA Genotype during Epidemic Waves in Rio de Janeiro, Southeast Brazil
por: Fabri, Allison Araújo, et al.
Publicado: (2020)

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)

The Presence of Virus Neutralizing Antibodies Is Highly Associated with Protection against Virulent Challenge in Domestic Pigs Immunized with ASFV live Attenuated Vaccine Candidates
por: Silva, Ediane B., et al.
Publicado: (2022)

Generation of a Live-Attenuated Strain of Chikungunya Virus from an Indian Isolate for Vaccine Development
por: Nair, Sreeja R., et al.
Publicado: (2022)

NOL7 facilitates melanoma progression and metastasis
por: Li, Yumei, et al.
Publicado: (2021)

Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003
por: Waickman, Adam T., et al.
Publicado: (2019)

Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children
por: Karron, Ruth A, et al.
Publicado: (2018)

Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis
por: Mahawar, Manish, et al.
Publicado: (2013)

A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever
por: Weise, William J., et al.
Publicado: (2014)

Discovery of Mosquito Saliva MicroRNAs during CHIKV Infection
por: Maharaj, Payal D., et al.
Publicado: (2015)

Impact of CHIKV Replication on the Global Proteome of Aedes albopictus Cells
por: Kumar, Ramesh, et al.
Publicado: (2022)

Peptide aptamer-based time-resolved fluoroimmunoassay for CHIKV diagnosis
por: Liu, Tonggong, et al.
Publicado: (2023)

Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates
por: Smith, Darci R., et al.
Publicado: (2018)

Transcriptome analysis of human macrophages upon chikungunya virus (CHIKV) infection reveals regulation of distinct signaling and metabolic pathways during the early and late stages of infection
por: Srivastava, Priyanshu, et al.
Publicado: (2023)

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates
por: Kari, Laszlo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v85g51rllfakhve0itg4427at4